Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of the Long-term Clinical Effects of Raising HDL Cholesterol With Extended Release Niacin/Laropiprant

NCT00461630 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00461630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00461630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of the Long-term Clinical Effects of Raising HDL Cholesterol With Extended Release Niacin/Laropiprant
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2012
Enrollment
25,673 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary heart disease, diabetes mellitus, peripheral arterial disease